title: [The clinico-laboratory assessment of the efficacy of dalargin in treating acute suppurative-inflammatory processes of the maxillofacial area].
abstract: The data obtained by the authors provide evidence on dalargin effect on immune condition of patients with pyoinfammation of maxillofacial soft tissues. Dalargin administration leads to a rise in T-sensitive lymphocyte subpopulation in all the patients as well as stimulates functional activity of peripheral blood polymorphonuclear neutrophils. Similar results were obtained in vitro with dalargin addition to leukocytic suspension despite the absence of the drug bactericidal activity.
authors.forename: N N
authors.initials: NN
authors.lastname: Bazhanov
authors.forename: S S
authors.initials: SS
authors.lastname: Ganina
authors.forename: S B
authors.initials: SB
authors.lastname: Pashutin
authors.forename: Ch R
authors.initials: ChR
authors.lastname: Ragimov
mesh_terms: D000208:Acute Disease; D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D002481:Cellulitis / Q000188:drug therapy* / Q000276:immunology; D003131:Combined Modality Therapy; D016308:Enkephalin, Leucine-2-Alanine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005145:Face; D005491:Focal Infection, Dental / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects / Q000276:immunology; D007571:Jaw Diseases / Q000188:drug therapy* / Q000276:immunology
chemical_list: D000276:Adjuvants, Immunologic; D016308:Enkephalin, Leucine-2-Alanine; C040996:enkephalin-Leu, Ala(2)-Arg(6)-
vernacular_title: Kliniko-laboratornaia otsenka éffektivnosti dalargina pri lechenii ostrykh gnoĭno-vospalitel'nykh protsessov cheliustno-litsevoĭ oblasti.